Philips Secured FDA 510(k) Clearance for Image-Guided Navigation Technology, Advancing Minimally Invasive Prostate Cancer Treatment
On July 23, 2025, Philips, a global leader in health technology, announced a significant milestone in prostate cancer care with the U.S. FDA 510(k) clearance of the latest version of its Philips UroNav system. This next-generation image-guided navigation platform introduces an advanced annotation workflow designed to support clinicians during focal therapy procedures, enabling greater precision and enhanced minimally invasive treatment. The enhanced UroNav system reflects Philips’ commitment to innovation in personalized cancer c...
